Results 181 to 190 of about 18,535 (225)

(Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide as carbonic anhydrase inhibitor: exploration of its in vitro and in silico studies. [PDF]

open access: yesBMC Chem
Ahmed A   +10 more
europepmc   +1 more source

Systematic Review on the Management of Diuretic Resistance in Acute Heart Failure across the Spectrum of Kidney Disease.

open access: yesCardiorenal Med
Marques P   +6 more
europepmc   +1 more source

Acetazolamide and Urolithiasis

Ophthalmology, 1981
Abstract: Interviews were conducted with 515 individuals between the ages of 20 and 80 years to gather data on acetazolamide therapy and the occurrence of urolithiasis. One hundred forty-eight patients were treated with chronic oral acetazolamide therapy for one week to 348 months (mean 40.9 months).
Bernard Becker   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy